Carol A. Gamble is SVP and General Counsel at Jazz Pharmaceuticals plc (JAZZ). They have made 5 open-market trades across 1 company since 2009, most recently 2012-03-09.
CIK 0001397267
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JAZZ | 32,213 | $6.8M |
Shares reported on the most recent Form 4, priced at the 2012-03-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL | 2012-03-09 | 2012-03-13 | $49.56 | $2.5M | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL | 2010-12-03 | 2010-12-03 | $17.77 | $444K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL | 2010-11-18 | 2010-11-19 | $15.57 | $874K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL | 2010-03-09 | 2010-03-10 | $11.41 | $165K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL | 2009-09-08 | 2009-09-08 | $9.28 | $32K | -10.8% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.